Kilpest India’s subsidiary company -- 3B BlackBio Biotech India has got an export order valued at Rs 2 crore (Rs 20 million) for its recently launched CE-IVD TRUPCR UTI ID Panel Kit and TRUPCR UTI AST Panel Kit. This RT-PCR based multiplex panel allows the detection and differentiation of 14 pathogens that cause urinary tract infections (UTI), as well as 14 antimicrobial resistance (AMR) genes encoding resistance to 5 class of antibiotics in one single run directly from native urine samples within 5 hours.
This assay will not only help in early diagnosis of patient infection but will also help the clinicians to judiciously select the most effective antibiotic class for treatment which can reduce spread and rise of antibiotic resistance. This export order will pave way for bigger opportunities as it bestows the trust of the company’s customers.
Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: